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Background
Alzheimer Disease (AD) is clinically characterized by glo-
bal, progressive and irreversible loss of mental faculties.
Neuropathologically is characterized by neurofibrillary
tangles and neuritic plaques; composed mainly by Amy-
loid β-peptide (Aβ). Generation, aggregation and degra-
dation of Aβ represent three important steps to be
considered in the study of the pathological mechanisms
implicated in AD. Several genes have been suggested as
implicated in each of these processes: Beta-site amyloid-
precursor protein cleaving enzyme (BACE) in generating,
Apolipoprotein E (APOE) in aggregation, and urokinase-
type plasminogen activator (PLAU), involved in degrada-
tion; have been exhaustively documented [1]. This is the
first study in Mexican population that analyzes genetic
risk factors related to AD.
Materials and methods
A case-control study was design to evaluate the possible
association between candidate genes involved in these
three processes with AD. Data collection was performed
from 49 patients with AD and 50 controls. We analyzed
alleles and genotype distributions for APOE (ε2/ε3/ε4), 2
APOE promoter polymorphisms −219 G/T and −491 T/A,
1SNP located in exon 5 of the BACE-1 gene (G/C), and
one (C/T) polymorphism in exon 6 of the PLAU gene.
Results
We found different allele and genotype frequencies for all
SNPs analyzed between cases and controls with exception
for −491 T/A. Association was found for the APOE ε4
allele (OR =2.42), −219 TT genotype (OR =1.77), CC gen-
otype of BACE-1 (OR =1.88) and TT genotype of PLAU
(OR =2.10).
Conclusions
These data suggest a genetic association between APOE
(ε4),−219TT, BACE-1 (CC), and PLAU (TT) genotypes
with AD in Mexican population.
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